Structure

Physi-Chem Properties

Molecular Weight:  416.22
Volume:  440.833
LogP:  5.405
LogD:  3.48
LogS:  -3.778
# Rotatable Bonds:  9
TPSA:  107.97
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.296
Synthetic Accessibility Score:  3.592
Fsp3:  0.5
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.809
MDCK Permeability:  1.4960260159568861e-05
Pgp-inhibitor:  0.057
Pgp-substrate:  0.922
Human Intestinal Absorption (HIA):  0.218
20% Bioavailability (F20%):  0.428
30% Bioavailability (F30%):  0.914

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.015
Plasma Protein Binding (PPB):  94.85919952392578%
Volume Distribution (VD):  1.131
Pgp-substrate:  5.0284833908081055%

ADMET: Metabolism

CYP1A2-inhibitor:  0.219
CYP1A2-substrate:  0.51
CYP2C19-inhibitor:  0.568
CYP2C19-substrate:  0.137
CYP2C9-inhibitor:  0.851
CYP2C9-substrate:  0.936
CYP2D6-inhibitor:  0.223
CYP2D6-substrate:  0.159
CYP3A4-inhibitor:  0.12
CYP3A4-substrate:  0.062

ADMET: Excretion

Clearance (CL):  9.959
Half-life (T1/2):  0.369

ADMET: Toxicity

hERG Blockers:  0.011
Human Hepatotoxicity (H-HT):  0.688
Drug-inuced Liver Injury (DILI):  0.902
AMES Toxicity:  0.064
Rat Oral Acute Toxicity:  0.309
Maximum Recommended Daily Dose:  0.424
Skin Sensitization:  0.573
Carcinogencity:  0.167
Eye Corrosion:  0.003
Eye Irritation:  0.025
Respiratory Toxicity:  0.153

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC288910

Natural Product ID:  NPC288910
Common Name*:   5,7-Dihydroxy-4-[(1S)-1-Hydroxypentyl]-8-(3-Methylbutanoyl)-6-(3-Methylbut-2-Enyl)Chromen-2-One
IUPAC Name:   5,7-dihydroxy-4-[(1S)-1-hydroxypentyl]-8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)chromen-2-one
Synonyms:  
Standard InCHIKey:  KDXSRMVJFBSRCC-KRWDZBQOSA-N
Standard InCHI:  InChI=1S/C24H32O6/c1-6-7-8-17(25)16-12-19(27)30-24-20(16)22(28)15(10-9-13(2)3)23(29)21(24)18(26)11-14(4)5/h9,12,14,17,25,28-29H,6-8,10-11H2,1-5H3/t17-/m0/s1
SMILES:  CCCC[C@@H](c1cc(=O)oc2c1c(O)c(CC=C(C)C)c(c2C(=O)CC(C)C)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1689176
PubChem CID:   51040688
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000145] Coumarins and derivatives
        • [CHEMONTID:0002908] Hydroxycoumarins
          • [CHEMONTID:0002909] 7-hydroxycoumarins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. n.a. n.a. PMID[21214226]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. stem n.a. PMID[21214226]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota Fruit n.a. n.a. Database[FooDB]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. n.a. Database[FooDB]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21645 Mammea americana Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT396 Cell Line T47D Homo sapiens IC50 = 910.0 nM PMID[491411]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 1140.0 nM PMID[491411]
NPT21802 PROTEIN FAMILY Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha Homo sapiens IC50 = 1720.0 nM PMID[491411]
NPT21802 PROTEIN FAMILY Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha Homo sapiens IC50 = 1810.0 nM PMID[491411]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC288910 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC133060
1.0 High Similarity NPC470554
1.0 High Similarity NPC118059
0.9928 High Similarity NPC184738
0.9928 High Similarity NPC474939
0.9928 High Similarity NPC470910
0.9928 High Similarity NPC470553
0.9928 High Similarity NPC307895
0.9928 High Similarity NPC96216
0.9928 High Similarity NPC470909
0.9928 High Similarity NPC33653
0.9855 High Similarity NPC294432
0.9855 High Similarity NPC470556
0.9855 High Similarity NPC112829
0.9638 High Similarity NPC19476
0.9638 High Similarity NPC241975
0.9577 High Similarity NPC285748
0.9571 High Similarity NPC472344
0.9565 High Similarity NPC470083
0.9565 High Similarity NPC199458
0.9565 High Similarity NPC219584
0.9565 High Similarity NPC183639
0.9514 High Similarity NPC470908
0.9514 High Similarity NPC474735
0.9493 High Similarity NPC138047
0.9493 High Similarity NPC474624
0.9493 High Similarity NPC131782
0.9441 High Similarity NPC177995
0.9441 High Similarity NPC474108
0.9379 High Similarity NPC327059
0.9379 High Similarity NPC321387
0.9315 High Similarity NPC290671
0.9241 High Similarity NPC472345
0.9236 High Similarity NPC181388
0.9236 High Similarity NPC470322
0.9231 High Similarity NPC18886
0.9225 High Similarity NPC470555
0.922 High Similarity NPC139554
0.9178 High Similarity NPC19238
0.9167 High Similarity NPC178627
0.9167 High Similarity NPC1886
0.9167 High Similarity NPC469935
0.9167 High Similarity NPC224714
0.9167 High Similarity NPC196137
0.9161 High Similarity NPC276565
0.9155 High Similarity NPC221173
0.9122 High Similarity NPC256141
0.9116 High Similarity NPC180351
0.9103 High Similarity NPC154217
0.9097 High Similarity NPC196459
0.9097 High Similarity NPC470296
0.9097 High Similarity NPC87609
0.9097 High Similarity NPC94794
0.9097 High Similarity NPC188632
0.9097 High Similarity NPC112791
0.9091 High Similarity NPC476508
0.9085 High Similarity NPC472343
0.9071 High Similarity NPC101752
0.9067 High Similarity NPC469936
0.9067 High Similarity NPC474738
0.9067 High Similarity NPC475797
0.9067 High Similarity NPC474609
0.9067 High Similarity NPC129053
0.9067 High Similarity NPC109967
0.9067 High Similarity NPC78554
0.9067 High Similarity NPC321372
0.9065 High Similarity NPC470984
0.9058 High Similarity NPC185624
0.9054 High Similarity NPC209142
0.9054 High Similarity NPC312549
0.9048 High Similarity NPC139966
0.9048 High Similarity NPC307052
0.9048 High Similarity NPC104236
0.9048 High Similarity NPC164205
0.9048 High Similarity NPC469932
0.9041 High Similarity NPC473133
0.9041 High Similarity NPC47388
0.9041 High Similarity NPC470670
0.9041 High Similarity NPC91902
0.9034 High Similarity NPC470890
0.9028 High Similarity NPC36181
0.9021 High Similarity NPC471587
0.9021 High Similarity NPC307990
0.9021 High Similarity NPC16455
0.9014 High Similarity NPC131130
0.9007 High Similarity NPC470397
0.9007 High Similarity NPC156910
0.9007 High Similarity NPC470983
0.9007 High Similarity NPC470982
0.9007 High Similarity NPC174999
0.9 High Similarity NPC108937
0.9 High Similarity NPC279218
0.8993 High Similarity NPC470988
0.898 High Similarity NPC469933
0.898 High Similarity NPC10097
0.898 High Similarity NPC208303
0.898 High Similarity NPC161864
0.898 High Similarity NPC470460
0.8973 High Similarity NPC472629
0.8958 High Similarity NPC74397
0.8958 High Similarity NPC201820
0.8951 High Similarity NPC23257
0.8936 High Similarity NPC84699
0.8936 High Similarity NPC60667
0.8919 High Similarity NPC470461
0.8919 High Similarity NPC5173
0.8913 High Similarity NPC21378
0.8913 High Similarity NPC470987
0.8912 High Similarity NPC249942
0.8912 High Similarity NPC202494
0.8912 High Similarity NPC140120
0.8912 High Similarity NPC85773
0.8912 High Similarity NPC297886
0.8904 High Similarity NPC294365
0.8904 High Similarity NPC206212
0.8904 High Similarity NPC473014
0.8904 High Similarity NPC235217
0.8904 High Similarity NPC297788
0.8904 High Similarity NPC124780
0.8904 High Similarity NPC71184
0.8904 High Similarity NPC87486
0.8904 High Similarity NPC469953
0.8889 High Similarity NPC477272
0.8882 High Similarity NPC269495
0.8881 High Similarity NPC470671
0.8881 High Similarity NPC470669
0.8881 High Similarity NPC470672
0.8881 High Similarity NPC474487
0.8881 High Similarity NPC474504
0.8881 High Similarity NPC470668
0.8881 High Similarity NPC36414
0.8874 High Similarity NPC469934
0.8873 High Similarity NPC470398
0.8873 High Similarity NPC470985
0.8873 High Similarity NPC470989
0.8873 High Similarity NPC268081
0.8867 High Similarity NPC273483
0.8865 High Similarity NPC125920
0.8865 High Similarity NPC236974
0.8865 High Similarity NPC144027
0.8859 High Similarity NPC38775
0.8859 High Similarity NPC61258
0.8859 High Similarity NPC37348
0.8859 High Similarity NPC476509
0.8857 High Similarity NPC285054
0.8851 High Similarity NPC145467
0.8851 High Similarity NPC240622
0.8851 High Similarity NPC168085
0.8851 High Similarity NPC471641
0.8851 High Similarity NPC471642
0.8851 High Similarity NPC240253
0.8844 High Similarity NPC474302
0.8844 High Similarity NPC474161
0.8844 High Similarity NPC57470
0.8844 High Similarity NPC127059
0.8844 High Similarity NPC470458
0.8844 High Similarity NPC24136
0.8844 High Similarity NPC187282
0.8844 High Similarity NPC290133
0.8844 High Similarity NPC285630
0.8844 High Similarity NPC476088
0.8836 High Similarity NPC125894
0.8836 High Similarity NPC475705
0.8836 High Similarity NPC117836
0.8836 High Similarity NPC185276
0.8836 High Similarity NPC85162
0.8836 High Similarity NPC107177
0.8836 High Similarity NPC223812
0.8836 High Similarity NPC278249
0.8836 High Similarity NPC476178
0.8836 High Similarity NPC77794
0.8836 High Similarity NPC81697
0.8836 High Similarity NPC51887
0.8828 High Similarity NPC110038
0.8828 High Similarity NPC248372
0.8828 High Similarity NPC166689
0.8828 High Similarity NPC282300
0.8828 High Similarity NPC17170
0.8828 High Similarity NPC156190
0.8828 High Similarity NPC96408
0.8828 High Similarity NPC321980
0.8828 High Similarity NPC279650
0.8828 High Similarity NPC258630
0.8828 High Similarity NPC470087
0.8819 High Similarity NPC471697
0.8819 High Similarity NPC53181
0.8819 High Similarity NPC472515
0.8819 High Similarity NPC240305
0.8819 High Similarity NPC217186
0.8819 High Similarity NPC37206
0.8819 High Similarity NPC473209
0.8811 High Similarity NPC38153
0.8811 High Similarity NPC332594
0.8811 High Similarity NPC253616
0.8811 High Similarity NPC255801
0.8811 High Similarity NPC322301
0.8808 High Similarity NPC193200
0.88 High Similarity NPC204561
0.88 High Similarity NPC309512
0.88 High Similarity NPC471677

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC288910 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8776 High Similarity NPD4378 Clinical (unspecified phase)
0.8649 High Similarity NPD2534 Approved
0.8649 High Similarity NPD2533 Approved
0.8649 High Similarity NPD2532 Approved
0.8636 High Similarity NPD7075 Discontinued
0.8562 High Similarity NPD2800 Approved
0.8562 High Similarity NPD7096 Clinical (unspecified phase)
0.8531 High Similarity NPD6651 Approved
0.8506 High Similarity NPD8443 Clinical (unspecified phase)
0.8497 Intermediate Similarity NPD6801 Discontinued
0.8493 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8487 Intermediate Similarity NPD4380 Phase 2
0.8442 Intermediate Similarity NPD7819 Suspended
0.8442 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8431 Intermediate Similarity NPD7411 Suspended
0.8425 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8425 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8367 Intermediate Similarity NPD1549 Phase 2
0.8356 Intermediate Similarity NPD2796 Approved
0.8333 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD5124 Phase 1
0.8311 Intermediate Similarity NPD1243 Approved
0.8289 Intermediate Similarity NPD920 Approved
0.8288 Intermediate Similarity NPD1510 Phase 2
0.828 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8272 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD7768 Phase 2
0.8212 Intermediate Similarity NPD6799 Approved
0.8158 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8146 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD1934 Approved
0.8138 Intermediate Similarity NPD1240 Approved
0.8133 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8067 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD3817 Phase 2
0.8027 Intermediate Similarity NPD1607 Approved
0.8013 Intermediate Similarity NPD6599 Discontinued
0.8013 Intermediate Similarity NPD3750 Approved
0.8012 Intermediate Similarity NPD6959 Discontinued
0.7987 Intermediate Similarity NPD1551 Phase 2
0.7987 Intermediate Similarity NPD2935 Discontinued
0.7975 Intermediate Similarity NPD2801 Approved
0.7974 Intermediate Similarity NPD1511 Approved
0.7963 Intermediate Similarity NPD5710 Approved
0.7963 Intermediate Similarity NPD5711 Approved
0.7939 Intermediate Similarity NPD7054 Approved
0.7939 Intermediate Similarity NPD7286 Phase 2
0.7935 Intermediate Similarity NPD5403 Approved
0.7927 Intermediate Similarity NPD7473 Discontinued
0.7919 Intermediate Similarity NPD2799 Discontinued
0.7892 Intermediate Similarity NPD7074 Phase 3
0.7892 Intermediate Similarity NPD7472 Approved
0.7879 Intermediate Similarity NPD3818 Discontinued
0.7877 Intermediate Similarity NPD2313 Discontinued
0.7875 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7871 Intermediate Similarity NPD1512 Approved
0.7866 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD6166 Phase 2
0.7844 Intermediate Similarity NPD5953 Discontinued
0.7831 Intermediate Similarity NPD5844 Phase 1
0.7826 Intermediate Similarity NPD3749 Approved
0.7812 Intermediate Similarity NPD5402 Approved
0.7806 Intermediate Similarity NPD5401 Approved
0.7798 Intermediate Similarity NPD7251 Discontinued
0.7798 Intermediate Similarity NPD6559 Discontinued
0.7778 Intermediate Similarity NPD919 Approved
0.7778 Intermediate Similarity NPD4628 Phase 3
0.7778 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD3882 Suspended
0.7751 Intermediate Similarity NPD7808 Phase 3
0.7751 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD422 Phase 1
0.7744 Intermediate Similarity NPD6232 Discontinued
0.774 Intermediate Similarity NPD6832 Phase 2
0.7738 Intermediate Similarity NPD6797 Phase 2
0.773 Intermediate Similarity NPD5494 Approved
0.7692 Intermediate Similarity NPD9717 Approved
0.7682 Intermediate Similarity NPD3748 Approved
0.7682 Intermediate Similarity NPD7033 Discontinued
0.7655 Intermediate Similarity NPD1203 Approved
0.7635 Intermediate Similarity NPD3268 Approved
0.7625 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD3226 Approved
0.7582 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD6002 Phase 3
0.7582 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD6005 Phase 3
0.7582 Intermediate Similarity NPD6004 Phase 3
0.7534 Intermediate Similarity NPD2797 Approved
0.7529 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7528 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD6100 Approved
0.7516 Intermediate Similarity NPD6099 Approved
0.7514 Intermediate Similarity NPD4363 Phase 3
0.7514 Intermediate Similarity NPD4360 Phase 2
0.7483 Intermediate Similarity NPD230 Phase 1
0.7468 Intermediate Similarity NPD2346 Discontinued
0.74 Intermediate Similarity NPD1296 Phase 2
0.74 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD1652 Phase 2
0.7368 Intermediate Similarity NPD447 Suspended
0.7368 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD1019 Discontinued
0.7365 Intermediate Similarity NPD1247 Approved
0.7358 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2344 Approved
0.7343 Intermediate Similarity NPD9545 Approved
0.7338 Intermediate Similarity NPD4308 Phase 3
0.7321 Intermediate Similarity NPD7229 Phase 3
0.7317 Intermediate Similarity NPD1465 Phase 2
0.7303 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD8312 Approved
0.7299 Intermediate Similarity NPD8313 Approved
0.7297 Intermediate Similarity NPD3267 Approved
0.7297 Intermediate Similarity NPD3266 Approved
0.7285 Intermediate Similarity NPD411 Approved
0.7284 Intermediate Similarity NPD7458 Discontinued
0.7284 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD4361 Phase 2
0.7278 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4908 Phase 1
0.7261 Intermediate Similarity NPD2654 Approved
0.7255 Intermediate Similarity NPD6355 Discontinued
0.7248 Intermediate Similarity NPD2798 Approved
0.723 Intermediate Similarity NPD3225 Approved
0.7226 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD1608 Approved
0.7203 Intermediate Similarity NPD9493 Approved
0.7188 Intermediate Similarity NPD7390 Discontinued
0.7175 Intermediate Similarity NPD8434 Phase 2
0.7171 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD2309 Approved
0.7166 Intermediate Similarity NPD7584 Approved
0.7152 Intermediate Similarity NPD37 Approved
0.7151 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1610 Phase 2
0.7126 Intermediate Similarity NPD4965 Approved
0.7126 Intermediate Similarity NPD4967 Phase 2
0.7126 Intermediate Similarity NPD4966 Approved
0.7117 Intermediate Similarity NPD1653 Approved
0.7108 Intermediate Similarity NPD8455 Phase 2
0.7103 Intermediate Similarity NPD1548 Phase 1
0.7099 Intermediate Similarity NPD6273 Approved
0.7095 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5890 Approved
0.7091 Intermediate Similarity NPD5889 Approved
0.7089 Intermediate Similarity NPD2424 Discontinued
0.7078 Intermediate Similarity NPD4307 Phase 2
0.7078 Intermediate Similarity NPD943 Approved
0.7069 Intermediate Similarity NPD1729 Discontinued
0.7066 Intermediate Similarity NPD5353 Approved
0.7066 Intermediate Similarity NPD4288 Approved
0.7059 Intermediate Similarity NPD7199 Phase 2
0.7059 Intermediate Similarity NPD6798 Discontinued
0.7055 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD6234 Discontinued
0.7039 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7585 Approved
0.7035 Intermediate Similarity NPD2403 Approved
0.7035 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD6667 Approved
0.7019 Intermediate Similarity NPD6666 Approved
0.7007 Intermediate Similarity NPD17 Approved
0.7006 Intermediate Similarity NPD5761 Phase 2
0.7006 Intermediate Similarity NPD5760 Phase 2
0.7 Intermediate Similarity NPD4287 Approved
0.7 Intermediate Similarity NPD7003 Approved
0.7 Intermediate Similarity NPD8151 Discontinued
0.6989 Remote Similarity NPD6104 Discontinued
0.6984 Remote Similarity NPD7583 Approved
0.6983 Remote Similarity NPD8150 Discontinued
0.6977 Remote Similarity NPD3926 Phase 2
0.6968 Remote Similarity NPD1613 Approved
0.6968 Remote Similarity NPD4060 Phase 1
0.6968 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6962 Remote Similarity NPD4477 Approved
0.6962 Remote Similarity NPD4476 Approved
0.6962 Remote Similarity NPD5408 Approved
0.6962 Remote Similarity NPD5404 Approved
0.6962 Remote Similarity NPD5406 Approved
0.6962 Remote Similarity NPD5405 Approved
0.6954 Remote Similarity NPD1164 Approved
0.6954 Remote Similarity NPD7228 Approved
0.6946 Remote Similarity NPD6844 Discontinued
0.6941 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6933 Remote Similarity NPD4749 Approved
0.6928 Remote Similarity NPD6585 Discontinued
0.6927 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6927 Remote Similarity NPD7783 Phase 2
0.6923 Remote Similarity NPD1933 Approved
0.6915 Remote Similarity NPD7435 Discontinued
0.6908 Remote Similarity NPD6917 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data